ChromaDex Announces Joint Venture in China
The signed agreement establishes beachhead to broadly market and distribute Tru Niagen® to Mainland China’s aging population LOS ANGELES–(BUSINESS WIRE)– ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced it has entered into an agreement (the “JV Agreement”) to establish a joint venture through its wholly owned subsidiary ChromaDex … Read more